iShares MSCI India ETF vs Philip Morris International Inc. — how do they compare? iShares MSCI India ETF trades at $45.93 (market cap $5.73B), while Philip Morris International Inc. trades at $200.39 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 54.5× iShares MSCI India ETF's market cap, and Philip Morris International Inc. pays a 3.19% dividend while iShares MSCI India ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 57 Days and Philip Morris International Inc. for 85 Days on average.
| INDA | PM | |
|---|---|---|
Market Cap | $5.73B | $312.50B |
Volume | 6,797,522 | 5,517,172 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $55.29 | $200.50 |
52-Week Low | $45.42 | $144.33 |
Typical Hold Time | 57 Days | 85 Days |
Enterprise Value | — | $355.62B |
Dividend Yield | — | 3.19% |
Signals from Pluang's Aura AI — not financial advice
INDA is trading at $46.12, down 1.31% with bearish technical signals dominating. The ETF faces headwinds from India's economic challenges including coal power shortages, monsoon concerns, and U.S. tariff tensions. Technical indicators show oversold conditions with RSI readings below 30, while moving averages signal strong bearish momentum. Recent news highlights structural issues in India's banking-heavy market composition despite overall economic growth.
The outlook remains cautious given India's energy security challenges and external trade pressures. Investment opportunity exists for long-term investors betting on India's growth story at current discounted levels, but risks include persistent power shortages, agricultural output concerns, and global trade tensions that could further pressure the ETF's performance.
Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.
Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →